JP2020530834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020530834A5 JP2020530834A5 JP2020502112A JP2020502112A JP2020530834A5 JP 2020530834 A5 JP2020530834 A5 JP 2020530834A5 JP 2020502112 A JP2020502112 A JP 2020502112A JP 2020502112 A JP2020502112 A JP 2020502112A JP 2020530834 A5 JP2020530834 A5 JP 2020530834A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- binding antibody
- matrix according
- antibody affinity
- matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023135227A JP2023179414A (ja) | 2017-07-17 | 2023-08-23 | アフェレーシスの方法及び使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762533579P | 2017-07-17 | 2017-07-17 | |
| US62/533,579 | 2017-07-17 | ||
| PCT/US2018/042553 WO2019018439A1 (en) | 2017-07-17 | 2018-07-17 | APHERESE METHODS AND ASSOCIATED USES |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023135227A Division JP2023179414A (ja) | 2017-07-17 | 2023-08-23 | アフェレーシスの方法及び使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020530834A JP2020530834A (ja) | 2020-10-29 |
| JP2020530834A5 true JP2020530834A5 (https=) | 2021-08-12 |
Family
ID=65016674
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502112A Pending JP2020530834A (ja) | 2017-07-17 | 2018-07-17 | アフェレーシスの方法及び使用 |
| JP2023135227A Pending JP2023179414A (ja) | 2017-07-17 | 2023-08-23 | アフェレーシスの方法及び使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023135227A Pending JP2023179414A (ja) | 2017-07-17 | 2023-08-23 | アフェレーシスの方法及び使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200164008A1 (https=) |
| EP (1) | EP3655001A4 (https=) |
| JP (2) | JP2020530834A (https=) |
| CN (1) | CN111225677A (https=) |
| AU (1) | AU2018304194B2 (https=) |
| BR (1) | BR112020000995A2 (https=) |
| CA (1) | CA3069880A1 (https=) |
| MX (1) | MX2020000713A (https=) |
| WO (1) | WO2019018439A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3384035A4 (en) | 2015-12-02 | 2019-08-07 | Voyager Therapeutics, Inc. | ASSAYS FOR THE DETECTION OF AAV-NEUTRALIZING ANTIBODIES |
| MY208145A (en) | 2018-06-18 | 2025-04-18 | Res Inst Nationwide Childrens Hospital | Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy |
| US11986536B2 (en) | 2019-03-23 | 2024-05-21 | Ablevia Biotech Gmbh | Compound for the sequestration of undesirable antibodies in a patient |
| EP3715374A1 (en) | 2019-03-23 | 2020-09-30 | Ablevia biotech GmbH | Compound for the sequestration of undesirable antibodies in a patient |
| KR20220133969A (ko) | 2020-01-28 | 2022-10-05 | 프리라인 테라퓨틱스 리미티드 | 바이러스 벡터에 대한 중화 항체 역가를 결정하기 위한 개선된 분석법 |
| IL299094A (en) * | 2020-06-15 | 2023-02-01 | Res Inst Nationwide Childrens Hospital | Administration of an adeno-associated virus vector for muscular dystrophies |
| CN111500635B (zh) * | 2020-07-02 | 2020-10-09 | 北京大学第三医院（北京大学第三临床医学院） | 一种包含携带核酸分子的载体的试剂盒 |
| RU2020122141A (ru) * | 2020-07-03 | 2022-01-04 | Максим Петрович Никитин | Способ и композиция на основе генотерапевтического агента и антитела, связывающегося с клетками крови |
| CN116547008A (zh) | 2020-09-23 | 2023-08-04 | 艾柏力维亚生技有限公司 | 用于增加病毒载体的效力的化合物 |
| US12071633B2 (en) | 2020-10-13 | 2024-08-27 | Kriya Therapeutics, Inc. | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer |
| AU2022363635A1 (en) * | 2021-10-16 | 2024-03-21 | Eliaz Therapeutics, Inc. | Apheresis of whole blood |
| US20250213707A1 (en) | 2022-03-24 | 2025-07-03 | Ablevia Biotech Gmbh | Compound for increasing efficacy of oncolytic viruses |
| WO2026028158A1 (en) * | 2024-07-31 | 2026-02-05 | Biohaven Therapeutics Ltd. | Targeted degradation of anti-aav antibodies to enable aav-based gene therapy |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU691297B2 (en) * | 1994-05-13 | 1998-05-14 | Miltenyi Biotec Gmbh | Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| US6406861B1 (en) * | 1998-10-07 | 2002-06-18 | Cell Genesys, Inc. | Methods of enhancing effectiveness of therapeutic viral immunogenic agent administration |
| EP1315551B1 (en) * | 1999-06-03 | 2015-11-04 | Advanced Extravascular Systems | One step removal of unwanted molecules from circulating blood |
| US6464976B1 (en) * | 1999-09-07 | 2002-10-15 | Canji, Inc. | Methods and compositions for reducing immune response |
| US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
| AT500483B1 (de) * | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| JP2010131033A (ja) * | 2007-03-16 | 2010-06-17 | Medical Science Co Ltd | 医療用吸着剤 |
| US8123713B2 (en) * | 2008-08-12 | 2012-02-28 | Caridian Bct, Inc. | System and method for collecting plasma protein fractions from separated blood components |
| US9546112B2 (en) * | 2010-03-22 | 2017-01-17 | Association Institut De Myologie | Methods of increasing efficiency of vector penetration of target tissue |
| US20130068691A1 (en) * | 2011-08-05 | 2013-03-21 | Henry John Smith | Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders |
| ES2857773T5 (es) * | 2011-08-24 | 2024-06-04 | Univ Leland Stanford Junior | Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos |
| SE1200356A1 (sv) * | 2011-10-30 | 2013-05-01 | Kurt Nilsson | Polymerbaserad produkt och användning |
| US9434928B2 (en) * | 2011-11-23 | 2016-09-06 | Nationwide Children's Hospital, Inc. | Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides |
| MX367100B (es) * | 2012-02-17 | 2019-08-05 | The Children´S Hospital Of Philadelphia | Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos. |
| US9717841B2 (en) * | 2012-09-11 | 2017-08-01 | Gary L. McNeil | Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source |
| IL297919A (en) * | 2013-07-22 | 2023-01-01 | Childrens Hospital Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| EP3204503A1 (en) * | 2014-10-06 | 2017-08-16 | Arthrogen BV | Aav-based gene therapy |
| EP3054007A1 (en) * | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step |
| US20180093032A1 (en) * | 2016-08-15 | 2018-04-05 | Henry John Smith | Targeted apheresis using binding agents or ligands immobilized on membranes |
| JP7610923B2 (ja) * | 2016-09-02 | 2025-01-09 | スパーク セラピューティクス インコーポレイテッド | Ｃｎｓ障害を治療するための方法及びベクター |
| WO2018109207A1 (en) * | 2016-12-16 | 2018-06-21 | Uniqure Ip B.V. | Immunoadsorption |
| WO2018158397A1 (en) * | 2017-03-02 | 2018-09-07 | Genethon | Method for removing anti-aav antibodies from a blood-derived composition |
| WO2019094253A1 (en) * | 2017-11-08 | 2019-05-16 | Avexis Inc. | Means and method for preparing viral vectors and uses of same |
-
2018
- 2018-07-17 US US16/631,692 patent/US20200164008A1/en active Pending
- 2018-07-17 BR BR112020000995-4A patent/BR112020000995A2/pt unknown
- 2018-07-17 JP JP2020502112A patent/JP2020530834A/ja active Pending
- 2018-07-17 CA CA3069880A patent/CA3069880A1/en active Pending
- 2018-07-17 MX MX2020000713A patent/MX2020000713A/es unknown
- 2018-07-17 CN CN201880060309.6A patent/CN111225677A/zh active Pending
- 2018-07-17 EP EP18835932.7A patent/EP3655001A4/en active Pending
- 2018-07-17 WO PCT/US2018/042553 patent/WO2019018439A1/en not_active Ceased
- 2018-07-17 AU AU2018304194A patent/AU2018304194B2/en active Active
-
2023
- 2023-08-23 JP JP2023135227A patent/JP2023179414A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020530834A5 (https=) | ||
| JP6991095B2 (ja) | ウイルスベクター精製における拡張可能な製造プラットフォームおよび遺伝子治療における使用のための高純度ウイルスベクター | |
| JP2023179414A (ja) | アフェレーシスの方法及び使用 | |
| JP7659523B2 (ja) | カラムに基づく高度にスケーラブルなｒＡＡＶの製造プロセス | |
| CN104520428B (zh) | 将基因转移到细胞、器官和组织的aav载体组合物和方法 | |
| JP2021522813A (ja) | プラスミドを用いないａａｖベクター産生細胞株 | |
| JP2015509711A5 (https=) | ||
| CN105579465B (zh) | 用于基因转移到细胞、器官和组织中的变异aav和组合物、方法及用途 | |
| JP2021532812A5 (https=) | ||
| JP2020526190A (ja) | Ａａｖベクターのカラム精製方法 | |
| JP2023179414A5 (https=) | ||
| JP2023511062A5 (https=) | ||
| EP4476241A1 (en) | Aav capsid variants and uses thereof | |
| JP2019524101A (ja) | 高収率の組換えアデノ随伴ウイルス（ｒＡＡＶ）ベクターを生成するための、規模拡大可能な高回収率の方法、及びそれにより生成される組換えアデノ随伴ウイルス（ｒＡＡＶ）ベクター | |
| US20240271159A1 (en) | Aav vector column purification methods | |
| WO2025038430A1 (en) | Aav capsid variants and uses thereof | |
| US20260000670A1 (en) | Prevention or mitigation of adverse effects related to recombinant viral vectors | |
| WO2025264565A1 (en) | Promoters | |
| WO2025264490A1 (en) | Dna promoters | |
| WO2025226891A1 (en) | Nucleic acid encoding ides | |
| RU2837753C2 (ru) | Вариант aav, композиции и способы, в которых он используется, а также способы его применения для переноса генов в клетки, органы и ткани |